Introduction
Preclinical models in OC research
Advantages | Disadvantages | |
---|---|---|
Cancer cell lines | Simple and easy to operate Can be used for high-throughput drug screening | Changes in the genome structure Cannot accurately represent the pathological characteristics of primordial cells |
Patient-derived xenograft (PDX) | Better representation of the nature of the tumor Preserves interaction with primary tumors Preserves the heterogeneity of primary tumors | Time consuming, expensive, and low success rate Existence of ethical problems Limitation of immunological activity in recipient mice Difficulty of cultivating low-grade malignant tumors Certain timeliness |
Genetically engineered rat model (GEMMS) | Complete immune function Evaluation of mutation sites in different tumors | Complex establishment process Cannot completely simulate a particular disease at the molecular level |
Non-mouse cancer model | ||
Drosophila melanogaster | Physiologically and pathologically similar to mammals Highly similar tumor signal transduction pathways to those in humans | No acquired immune function Short life cycle Cannot reflect cancer changes over time |
Nematode | Grows fast and multiplies in large numbers Transparent body and easy to observe Completed genome sequencing | Structure is too simple Low similarity with human structure |
Zebrafish | High homology with human genome Tenacious vitality and easy to cultivate Short generation Clear genetic background | Source species are difficult to determine Modeling engineering needs to be improved |
Spheroid | Study on drug resistance and metastasis Produces PDX to evaluate the tumorigenicity of primary tumors Enrichment of stem cell-like cells in spheroid | Lack of control group Normal epithelial cells cannot be cultured Low success rate of cultivation |
Organoids | Can be cultured on a large scale and high-throughput drug screening Various subtypes can be cultured Tumor gene expression profile can be maintained in a long-term culture Maintains good genetic stability and tumor heterogeneity Better simulation of hypoxic microenvironment of tumors | Lacks matrix, immune cells, and blood vessels Expensive Low success rate of culture of some subtypes of tumors |
Cancer cell lines
Animal model in vivo
Spheroid
Organoid
Tissue | Cancer type | Source of organoid | References |
---|---|---|---|
Lung | Non-small cell lung cancer (NSCLC) | Human primary tumor and patient-derived xenograft (PDX) | Tsao ([39], p 11) |
Lung cancer | Human primary tumor | Ishii ([40], p 8) | |
Pancreas | Pancreatic cancer | Human primary tumor | Knudsen ([41], p 11) Saif ([42], p 7) Haibe-Kains ([43], p 1) |
Human primary tumor and normal pancreas | Tuveson ([44], p 11) | ||
Splenic xenograft mouse | Nakamura ([45], p 5) | ||
Pancreatic ductal adenocarcinoma (PDAC) | PDX | Kim ([46], p 9) | |
Human primary tumor | Hippo ([47], p 6) Welsch ([48], p 6) | ||
Esophagus | Esophageal adenocarcinoma | Barrett's esophagus (BE) tissue of mice | Quante ([49], p 8) |
Stomach | Gastric cancer | Malignant ascites of gastric cancer | Zhan ([50], p 11) |
Human primary tumor | Yu ([51], p 5) | ||
Human primary tumor and normal stomach | Zavros ([52], p 1) | ||
Breast | Breast cancer | Human primary tumor | Raouf ([53], p 9) Corsi ([54], p 7) Skala ([55], p 6) |
Human primary tumor and decellularized rat | Bruno ([56], p 9) | ||
The heterogeneity of triple-negative breast cancer (TNBC) | Human primary tumor | Park ([57], p 9) | |
Brain | Head and Neck Cancer | Normal and tumor patient-material | Oliveira ([58], p 11) |
Head and neck squamous cell carcinoma (HNSCC) | Human primary tumor | Clevers ([59], p 7) | |
glioblastoma (GBM) | Patient-derived glioma stem cells (GSCs) and human embryonic stem cell (hESC) | Fine ([60], p 5) | |
Prostate | Prostatic cancer | Human primary tumor and metastatic cell lines | Kotula ([61], p 9) |
Mouse prostate | Sawyers ([62], p 7) | ||
Genetically engineered mouse models (GEMMs) | Goodrich ([63], p 6) | ||
Bladder | Bladder cancer | Urine samples of dogs | Sasaki ([64], p 9) |
Human primary tumor and normal mouse urothelium | Clevers ([65], p 3) | ||
Liver | Liver cancer | Human primary hepatic stellate cells (HSCs) | Jung ([66], p 10) |
Directly reprogrammed human hepatocytes (hiHeps) | Hui ([67], p 8) | ||
Normal human cholang iocyte | Clevers ([68], p 6) | ||
human primary tumor | Selaru ([69], p 1) | ||
Cholangiocarcinoma (CCA) | Liver of mouse | Saborowski ([70], p 3) | |
Hepatocellular carcinoma (HCC) | Human primary tumor | Ma ([71], p 8) | |
Colorectal | Colon cancer | Human primary tumor | Muñoz ([72], p 11) |
Human primary tumor and normal colon, normal mouse small intestine and colon | Nold ([73], p 10) | ||
Human primary tumor and normal colon | Barbáchano ([74], p 7) | ||
Colorectal cancer | Human primary tumor | Kurisawa ([75], p 10) Kops ([76], p 5) Wiener ([77], p 6) Yao ([78], p 4) | |
Mouse intestinal tumor and PDX | Oshima ([79], p 7) | ||
Human normal colon | Kitagawa ([80], p 6) | ||
Colon signet-ring cell carcinoma (SRCC) | Human primary tumor | Peng ([81], p 11) | |
Traditional serrated adenomas (TSAs) | Human normal colon | Sato ([82], p 10) | |
Metastatic colorectal cancer (mCRC) | Human primary tumor | Banerjee ([83], p 2) | |
Lymph | Non-Hodgkin lymphoma | Human primary tumor | Pérez-Galán ([84], p 7) |
Cervix | Cervical clear cell carcinoma (cCCC) | Human primary tumor | Hippo ([85], p 9) |
Endometrium | Endometrial cancer | Human primary tumor | Hippo ([86], p 5) |
Endometrial disorders | The primary tissue | Vankelecom ([87], p 8) | |
Ovary | Ovarian cancer | Human primary tumor and normal tissue | Clevers, Hans ([88], p 5) |
Kidney | Renal cancer | Human primary tumor | Bonci ([89], p 2) |